Biotech

All Articles

Biogen containers SAGE-324 collaboration after necessary shake fall short

.Biogen has provided the final ceremonies to its own cooperation with Sage Therapies on SAGE-324, di...

AbbVie Parkinson's medicine from $8.7 B Cerevel acquistion scores

.On the exact same time that some Parkinson's condition medicines are actually being disputed, AbbVi...

Arch shuts $3B-plus fund to nurture biopharma upstarts

.On the heels of a $3 billion fund coming from Bain Resources Lifestyle Sciences, Arc Project Partne...

Orion to make use of Aitia's 'digital doubles' to discover new cancer cells medications

.Finnish biotech Orion has actually spied possible in Aitia's "electronic double" technology to cult...

Windtree's shock med rears blood pressure in most recent stage 2 gain

.While Windtree Therapeutics has struggled to increase the monetary origins needed to have to endure...

2 cancer cells biotechs combine, creating worldwide footprint

.OncoC4 is taking AcroImmune-- as well as its internal professional production capacities-- under it...

Amgen reports 1st stage 3 win for $400M dermatitis medicine

.Amgen has actually discussed (PDF) the first phase 3 records on its $400 thousand chronic eczema me...

Biogen, UCB document stage 3 lupus succeed after neglecting earlier trial

.Biogen and also UCB's bank on improving in to period 3 astride an unsuccessful study tries to have ...

Aptadir hopes new RNA inhibitors can easily turn around complicated cancers

.Italian biotech Aptadir Therapeutics has released with the commitment that its own pipe of preclini...

Wave surfs DMD success to regulatory authorities' doors, delivering stock up

.Surge Lifestyle Sciences has met its objective in a Duchenne muscle dystrophy (DMD) research study,...